The biotech’s overhaul will see the company focus on its late-stage Merck ($MRK) Ebola vaccine collaboration and other R&D programs including a … Full Article http://j.gs/5sTq
Click here to read full articleThe biotech’s overhaul will see the company focus on its late-stage Merck ($MRK) Ebola vaccine collaboration and other R&D programs including a … Full Article http://j.gs/5sTq
Click here to read full article
No comments:
Post a Comment